As a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, it may surpass even tirzepatide for weight loss based on early clinical data
Always check labels to calculate total daily intake and consult your GP if unsure
Nature Communications, 11(1)
Only qualified professionals with appropriate expertise should manage and handle this product
Adverse reactions following intramuscular (IM) injection have included anxiety, mild transient diarrhea, ataxia, nervousness, pruritus, transitory exanthema, and a feeling of swelling of the entire body
AOD 9604 does not share this effect